http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CO-5910040-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5202e138b73ab3e1bf1358618846de9e |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-549 |
| filingDate | 2007-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab38bdfeb58b451e1bf3447ee93e2f8c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_730e93c57f7cfa8956a121184551cf21 |
| publicationDate | 2008-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CO-5910040-A1 |
| titleOfInvention | A PHARMACEUTICAL PRESENTATION IN THE FORM OF A SOFT GELATINE CAPSULE THAT INCLUDES AN ANTAGONIST OF THE ANGIOTENSIN II RECEPTORS AND A DIURETIC AS WELL AS THE PROCESS TO CONFORM THE PRESENTATION |
| abstract | 1.- A pharmaceutical presentation in the form of a soft gelatin capsule CHARACTERIZED BECAUSE the capsule is filled with a transparent solution and comprises in combination: (a) an agent for the treatment of hypertension, congestive diseases and post acute myocardial infarction or its pharmaceutically acceptable salt; (b) a diuretic; (c) a mixture of pharmaceutically acceptable solvents; (d) a solubility aid; and, optionally (e) an ionizing agent and (f) water. 2. A pharmaceutical presentation in the form of a soft gelatin capsule according to claim 1, CHARACTERIZED BECAUSE the agent for the treatment of arterial hypertension, congestive diseases and post acute myocardial infarction is an antagonist of angiotensin II receptors, such as the Valsartan. 3. A pharmaceutical presentation in the form of a soft gelatin capsule according to claim 2, CHARACTERIZED BECAUSE Valsartan is present in said pharmaceutical presentation, in an amount that can vary from 5% to 90% of the total weight, preferably between 10% to 70% of total weight. 4. A pharmaceutical presentation in the form of a soft gelatin capsule according to claim 1, CHARACTERIZED BECAUSE the diuretic is selected from the group of: loop diuretics, thiazide diuretics, carbonic anhydrase inhibitor diuretics and potassium-sparing diuretics. |
| priorityDate | 2007-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 17.